Extra JM - Search Results

1

Capecitabine after anthracycline and taxane exposure in HER2-negative metastatic breast cancer patients: response, survival and prognostic factors.

Gilabert M, Bertucci F, Esterni B, Madroszyk A, Tarpin C, Jacquemier J, Extra JM, Viens P, Gonçalves A. Gilabert M, et al. Among authors: extra jm. Anticancer Res. 2011 Mar;31(3):1079-86. Anticancer Res. 2011. PMID: 21498742

2

[High dose chemotherapy with autologous bone marrow transplantation in ovarian adenocarcinoma].

Extra JM, Cure H, Viens P, Maraninchi D, Legros M, Marty M. Extra JM, et al. Bull Cancer. 1993 Feb;80(2):156-62. Bull Cancer. 1993. PMID: 8173168 French.

3

Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancer.

Robain M, Pierga JY, Jouve M, Asselain B, Diéras V, Beuzeboc P, Palangié T, Dorval T, Extra JM, Scholl S, Pouillart P. Robain M, et al. Among authors: extra jm. Eur J Cancer. 2000 Dec;36(18):2301-12. doi: 10.1016/s0959-8049(00)00325-7. Eur J Cancer. 2000. PMID: 11094303

4

Response to chemotherapy is a major parameter-influencing long-term survival of metastatic breast cancer patients.

Pierga JY, Robain M, Jouve M, Asselain B, Diéras V, Beuzeboc P, Palangié T, Dorval T, Extra JM, Scholl S, Pouillart P. Pierga JY, et al. Among authors: extra jm. Ann Oncol. 2001 Feb;12(2):231-7. doi: 10.1023/a:1008330527188. Ann Oncol. 2001. PMID: 11300330 Free article. Clinical Trial.

5

Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes.

Rouzier R, Extra JM, Klijanienko J, Falcou MC, Asselain B, Vincent-Salomon A, Vielh P, Bourstyn E. Rouzier R, et al. Among authors: extra jm. J Clin Oncol. 2002 Mar 1;20(5):1304-10. doi: 10.1200/JCO.2002.20.5.1304. J Clin Oncol. 2002. PMID: 11870173

6

Protein profiling of human breast tumor cells identifies novel biomarkers associated with molecular subtypes.

Gonçalves A, Charafe-Jauffret E, Bertucci F, Audebert S, Toiron Y, Esterni B, Monville F, Tarpin C, Jacquemier J, Houvenaeghel G, Chabannon C, Extra JM, Viens P, Borg JP, Birnbaum D. Gonçalves A, et al. Among authors: extra jm. Mol Cell Proteomics. 2008 Aug;7(8):1420-33. doi: 10.1074/mcp.M700487-MCP200. Epub 2008 Apr 20. Mol Cell Proteomics. 2008. PMID: 18426791 Free PMC article.

7

Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer.

Jacquemier J, Charafe-Jauffret E, Monville F, Esterni B, Extra JM, Houvenaeghel G, Xerri L, Bertucci F, Birnbaum D. Jacquemier J, et al. Among authors: extra jm. Breast Cancer Res. 2009;11(2):R23. doi: 10.1186/bcr2249. Epub 2009 Apr 30. Breast Cancer Res. 2009. PMID: 19405945 Free PMC article.

8

Docetaxel first-line therapy in HER2-negative advanced breast cancer: a cohort study in patients with prospectively determined HER2 status.

Gonçalves A, Deblock M, Esterni B, Tarpin C, Bertucci F, Gilabert M, Charafe-Jauffret E, Jacquemier J, Houvenaeghel G, Extra JM, Viens P. Gonçalves A, et al. Among authors: extra jm. Anticancer Drugs. 2009 Nov;20(10):946-52. doi: 10.1097/CAD.0b013e328331178f. Anticancer Drugs. 2009. PMID: 19741502

9

Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.

Charafe-Jauffret E, Ginestier C, Iovino F, Tarpin C, Diebel M, Esterni B, Houvenaeghel G, Extra JM, Bertucci F, Jacquemier J, Xerri L, Dontu G, Stassi G, Xiao Y, Barsky SH, Birnbaum D, Viens P, Wicha MS. Charafe-Jauffret E, et al. Among authors: extra jm. Clin Cancer Res. 2010 Jan 1;16(1):45-55. doi: 10.1158/1078-0432.CCR-09-1630. Epub 2009 Dec 22. Clin Cancer Res. 2010. PMID: 20028757 Free PMC article.

10

A gene expression signature identifies two prognostic subgroups of basal breast cancer.

Sabatier R, Finetti P, Cervera N, Lambaudie E, Esterni B, Mamessier E, Tallet A, Chabannon C, Extra JM, Jacquemier J, Viens P, Birnbaum D, Bertucci F. Sabatier R, et al. Among authors: extra jm. Breast Cancer Res Treat. 2011 Apr;126(2):407-20. doi: 10.1007/s10549-010-0897-9. Epub 2010 May 21. Breast Cancer Res Treat. 2011. PMID: 20490655 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters